Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative Activity
Citations Over TimeTop 11% of 2010 papers
Abstract
Structural modifications to the coumarin core and benzamide side chain of novobiocin have successfully transformed the natural product from a selective DNA gyrase inhibitor into a potent inhibitor of the Hsp90 C-terminus. However, no SAR studies have been conducted on the noviose appendage, which represents the rate-limiting synthon in the preparation of analogues. Therefore, a series of sugar mimics and non-sugar derivatives were synthesized and evaluated to identify simplified compounds that exhibit Hsp90 inhibition. Evaluation against two breast cancer cell lines demonstrated that replacement of the stereochemical complex noviose with simplified alkyl amines increased anti-proliferative activity, resulting in novobiocin analogues that manifest IC(50) values in the mid nanomolar range.
Related Papers
- → Alteration of Escherichia coli Topoisomerase IV to Novobiocin Resistance(2003)63 cited
- → GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin(1996)56 cited
- → Interplay of novobiocin-resistant and -sensitive DNA gyrase activities in self-protection of the novobiocin producer, Streptomyces sphaeroides(1989)45 cited
- → Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase(1984)43 cited
- → Discrepancy between the Antibacterial Activities and the Inhibitory Effects on <i>Micrococcus luteus</i> DNA Gyrase of 13 Quinolones(1986)19 cited